Image
Pioneering Synthetic Ligament Technology to Keep You Moving
Over 30 years advancing the future of sports medicine

Movmedix is a global leader in synthetic ligament technology, trusted by surgeons worldwide for over three decades. Originating in 1992 as LARS (Laboratoire d’Application et de Recherche Scientifique), our pioneering LARS® ligaments have transformed treatment for knee and shoulder injuries. Today, Movmedix continues to push boundaries with next-generation solutions-empowering patients to move, heal, and thrive.

Image
Pioneering Synthetic Ligament Technology to Keep You Moving
Over 30 years advancing the future of sports medicine

Movmedix is a global leader in synthetic ligament technology, trusted by surgeons worldwide for over three decades. Originating in 1992 as LARS (Laboratoire d’Application et de Recherche Scientifique), our pioneering LARS® ligaments have transformed treatment for knee and shoulder injuries. Today, Movmedix continues to push boundaries with next-generation solutions-empowering patients to move, heal, and thrive.

Image
Pioneering Synthetic Ligament Technology to Keep You Moving
Over 30 years advancing the future of sports medicine

Movmedix is a global leader in synthetic ligament technology, trusted by surgeons worldwide for over three decades. Originating in 1992 as LARS (Laboratoire d’Application et de Recherche Scientifique), our pioneering LARS® ligaments have transformed treatment for knee and shoulder injuries. Today, Movmedix continues to push boundaries with next-generation solutions-empowering patients to move, heal, and thrive.

Image
Pioneering Synthetic Ligament Technology to Keep You Moving
Over 30 years advancing the future of sports medicine

Movmedix is a global leader in synthetic ligament technology, trusted by surgeons worldwide for over three decades. Originating in 1992 as LARS (Laboratoire d’Application et de Recherche Scientifique), our pioneering LARS® ligaments have transformed treatment for knee and shoulder injuries. Today, Movmedix continues to push boundaries with next-generation solutions-empowering patients to move, heal, and thrive.

Image
Pioneering Synthetic Ligament Technology to Keep You Moving
Over 30 years advancing the future of sports medicine

Movmedix is a global leader in synthetic ligament technology, trusted by surgeons worldwide for over three decades. Originating in 1992 as LARS (Laboratoire d’Application et de Recherche Scientifique), our pioneering LARS® ligaments have transformed treatment for knee and shoulder injuries. Today, Movmedix continues to push boundaries with next-generation solutions-empowering patients to move, heal, and thrive.

previous arrow
next arrow
A Growing challenge for athletes and active patients worldwide

The Hidden Cost of Soft Tissues Injuries

Soft tissue injuries are a major global health challenge. Each year:

  • Hundreds of thousands of ACL injuries occur across North America, Europe, and Asia¹.
  • Over 250,000 rotator cuff repairs are performed annually in developed countries², with prevalence increasing in active adults worldwide.
 
These injuries carry long rehabilitation periods and a high risk of long-term joint degeneration, including knee osteoarthritis and chronic shoulder dysfunction2,3. The economic and societal impact is substantial, with healthcare costs, lost productivity, and long-term disability contributing billions of dollars annually across the major markets of the U.S., Europe, and Asia3,4. Innovations in ligament and tendon reconstruction – including minimally invasive techniques and synthetic or biomimetic grafts – are reshaping treatment globally, aiming for faster recovery and more durable outcomes.

Sources:

¹ Mall NA et al., J Bone Joint Surg Am, 2014;96(23):e190

² Arundale AJH et al., Br J Sports Med, 2018;52(23):1437–1444

³ Øiestad BE et al., Am J Sports Med, 2009;37(7):1434–1443

4 Mather RC III et al., Am J Sports Med, 2013;41(12):2616–2622

200,000+

ACL injuries / year (U.S)

Up to 12 months

recovery

3x higher risk

of osteoarthritis

>$2 billion

annual cost (U.S.)4

Pioneering free fibers technology in synthetics, with a global reach

Introducing LARS® to restore infinite mobility to patients

The Ligament Advanced Reinforcement System (LARS®) is a third-generation artificial ligament made from biocompatible polyethylene terephthalate (PET). Engineered for durability and precision, LARS® ligaments feature two distinct sections – intra-osseous and intra-articular – with free fiber technology, enabling natural movement and accelerated recovery. Trusted worldwide, LARS® represents a leap forward in ligament reconstruction and reinforcement, delivering consistent outcomes for soft tissue injuries.

Where cutting-edge science meets decades of local manufacturing

Precision, Excellence, and French Expertise

Rooted in the innovation spirit of French medical engineering, LARS® ligaments are designed and manufactured with meticulous precision, and represents the pinnacle of advanced ligament repair solutions.

Combining scientific innovation with decades of expertise, the Ligament Augmentation and Reconstruction System embodies the excellence, reliability, and ingenuity that surgeons and patients worldwide have come to expect.